Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1148-1155

  Schilling, J D ^a   Mulvey, M A ^a   Vincent, C D ^a   Lorenz, R G ^a   Hultgren, S J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIUM PILUS; BLADDER EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035863909     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1148     Document Type: Article

References (54)

1. Intestinal epithelial cells as watchdogs for the natural immune system
2. Epithelial cells as sensors for microbial infection
3. Diagnosis and treatment of uncomplicated urinary tract refection
4. The structure, function, synthesis and genetic control of bacterial pill and a molecular model for DNA and RNA transport in Gramnegative bacteria
5. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae
6. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination
7. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli
8. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. [Published erratum appears in 1991 Science 283:795]
9. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells
10. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro
11. Bacterial adherence and mucosal cytokine responses: Receptors and transmembrane signaling
12. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors
13. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14
14. Tlr4: Central component of the sole mammalian LPS sensor
15. CD14-deficient mice are exquisitely insensitive to the effects of LPS
16. Murine CD14 gene expression in vivo: Extramyeloid synthesis and regulation by lipopolysaccharide
17. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses
18. Cytokine responses during mucosal infections: Role in disease pathogenesis and host defence
19. Type 1 fimbriae mutants of Escherichia coli K12: Characterization of recognized afimbriate strains and construction of new tim deletion mutants
20. Bacterial lipopolysaccharide activates NF-κB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: Differential expression of TLR-4 and TLR-2 in endothelial cells
21. Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses
22. Impaired immune and acute-phase responses in interleukin-6-deficient mice
23. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
24. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
25. IL-6 and APPs: Antiinflammatory and immunosuppressive mediators
26. Epithelial cytokine responses and mucosal cytokine networks
27. Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection
28. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli
29. Bacterial perturbation of cytokine networks
30. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
31. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2
32. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
33. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
34. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice
35. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains
36. Neutrophil recruitment and resistance to urinary tract infection
37. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection
38. Host resistance to mucosal gramnegative infection: Susceptibility of lipopolysaccharide nonresponder mice
39. Interleukin-6 induced at mucosal surfaces by gramnegative bacterial infection
40. Cutting edge: Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein
41. Protective immunity induced in mice by detoxified salmonella lipopolysaccharide
42. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway
43. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway
44. The Tol-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
45. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
46. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
47. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components
48. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
49. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
50. The innate immune response of the respiratory epithelium
51. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli
52. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors
53. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
54. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukinsignaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes